HempNewsBreaks – India Globalization Capital (NYSE: IGC) Aims to Fast-Track Release of Hyalolex in Recreational Cannabis States

As a first mover in the cannabis-based combination therapy space, India Globalization Capital (NYSE AMERICAN: IGC) is preparing for the launch of its breakthrough treatment aimed at reducing beta-amyloid building up in Alzheimer’s patients, Hyalolex. The classification as a combination therapy enables the company to bring the product to market significantly faster than most pharmaceuticals, because Hyalolex does not need FDA approval. An article discussing this reads: “This hugely accelerated introduction of Hyalolex can only be accomplished in states where medical cannabis is legal and where the ailment (in this case Alzheimer’s) is an approved medical condition. In states where recreational cannabis has been approved, IGC doesn’t have to contend with whether or not Alzheimer’s is an approved medical condition in order to bring its treatment to market. Therefore, these states (recreational marijuana states like California, Colorado, Oregon, etc.) will be targeted first with IGC’s cannabis-based Alzheimer’s treatment.”

To view the full article, visit http://cnw.fm/E6XxO

About IGC

IGC is engaged in the development of cannabis based combination therapies to treat Alzheimer’s, pain, nausea, eating disorders, several end points of Parkinson’s, and epilepsy in dogs and cats. IGC has assembled a portfolio of patent filings and four lead product candidates addressing these conditions. The company is based in Maryland, USA. For more information please visit www.igcinc.us.

More from CannabisNewsBreaks

• HempNewsBreaks – Turning Point Brands Inc. (NYSE: TPB) Closes $300M Senior Secured Notes Offering 
• HempNewsBreaks – WEED Inc. (BUDZ) Announces 2024 Highlights, Plans to Expand into Consumer Packaged Goods
• HempNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Closes $3.6M Registered Direct

About HempWire

HempWire (HW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) HempNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, HW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. HW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, HW brings its clients unparalleled visibility, recognition and brand awareness. HW is where news, content and information converge.

For more information please visit https://www.hempwire.com

Please see full terms of use and disclaimers on the HempWire website applicable to all content provided by HW, wherever published or re-published: https://www.hempwire.com/disclaimer/

HempWire (HW)
Denver, Colorado
www.hempwire.com
303.498.7722 Office
Editor@HempWire.net